Kirk Tsahalis

Kirk Tsahalis currently serves as the Head of US Business Development for Injectables at Hikma Pharmaceuticals, overseeing business development activities across generics, branded products, biosimilars, and animal health since November 2023. Previously, as Managing Member of Pantheon Advisors LLC, Kirk provided consulting solutions to the pharmaceutical sector. Kirk held multiple leadership roles at Akorn Pharmaceuticals, including Vice President of Global Procurement & Business Development and Executive Director of Global Procurement, where significant savings and a centralized procurement operation were established. Kirk also gained experience at Teva Pharmaceuticals in global pipeline analytics and sales and marketing at Teva Active Pharmaceutical Ingredients, contributing to product selection and managing substantial sales portfolios. Earlier experience includes consulting for Fino Consulting and an internship with ExxonMobil. Kirk Tsahalis earned an MBA from Cornell Johnson Graduate School of Management and holds a Bachelor of Science degree in Chemical Engineering from Cornell University.